[1]
H. Miyake, K.- ichi Harada, Y. Matsushita, N. Hinata, H. Sugimura, and M. Fujisawa, “Protocol for a prospective multicenter intervention study (URivo study) assessing biomarkers in patients with previously treated advanced clear cell renal cell carcinoma receiving nivolumab”, Int J Clin Trials, vol. 6, no. 2, pp. 63–68, Apr. 2019.